A computational biology company SilicoLife and INVISTA have entered into a collaboration for the development of new technologies to enable bio-derived processes for the production of industrial chemicals. The two companies are collaborating in order to further co-develop their technology platforms. One of the initial focus areas will be bio-derived production of butadiene. The agreement will utilize INVISTA’s capabilities in biotechnology and catalysis, and knowledge of the chemicals industry, and SilicoLife’s computational models of microbial cells and developing proprietary state-of-the-art algorithms to find the most efficient pathways between raw-material and end-product. The move follows a similar deal with LanzaTech last year, which is expected to go commercial in 2016.
14-Aug-13 
{{comment.DateTimeStampDisplay}}
{{comment.Comments}}